CVS Health (CVS) Tops Q4 EPS by 5c, Revenue Beats, Offers FY20 Guidance

CVS Health (NYSE: CVS) reported Q4 EPS of $1.73, $0.05 better than the analyst estimate of $1.68. Revenue for the quarter came in at $66.9 billion versus the consensus estimate of $63.97 billion.

GUIDANCE:

CVS Health sees FY2020 EPS of $7.04-$7.17, versus the consensus of $7.15.

• GAAP operating income in the range of $12.8 billion to $13.0 billion
• Adjusted operating income (1) in the range of $15.5 billion to $15.8 billion
• GAAP diluted EPS from continuing operations in the range of $5.47 to $5.60
• Adjusted EPS (2) in the range of $7.04 to $7.17
• Cash flow from operations in the range of $10.5 billion to $11.0 billion

For earnings history and earnings-related data on CVS Health (CVS) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Jefferies Starts DBS Group Holdings (DBS:SP) (DBSDY) at Buy
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk